ICEP uses cutting-edge statistical methods and genetic data (including data on gene products such as proteins, and chemical alterations to genes such as DNA methylation) on tens to hundreds of thousands of people to provide high quality evidence on:

• the causes of cancers
• factors influencing cancer progression
• new ways to predict who will develop or die from cancers
• new ways to prevent cancer and its progression, including behavioural and therapeutic interventions

This knowledge will contribute towards new interventions to prevent, detect early and treat cancers, as well targeting prevention measures and treatments to those most at risk.

Our programme focuses on cancers that are common, present late or have poor survival rates, including bowel (colorectum), brain (glioma), breast, head and neck, kidney, lung, ovarian, pancreatic and prostate cancers.